Literature DB >> 507283

Transmission of Venezuelan encephalitis virus by naturally infected Culex (Melanoconion) opisthopus.

E W Cupp, W F Scherer, J V Ordonez.   

Abstract

During August 1977 two of 975 Culex (Melanoconion) opisthopus collected from an enzootic marsh habitat on the Pacific coast of Guatemala transmitted VE virus to hamsters. Eight VE strains were isolated from Cu. opisthopus. The minimal level of VE infection in this species during July-August 1977 at La Avellana, Guatemala was 1/128 (8/1,021), and the prevalence of Cu. (Mel.) opisthopus transmitting VE virus was 1/487 (2/975). This mosquito was the predominant species attacking humans at that time, suggesting that Cu. opisthopus is a vector of VE virus to man as well as a vector in enzootic cycles in Guatemala. These studies establish Cu. opisthopus as the third proven enzootic vector of VE virus.

Entities:  

Mesh:

Year:  1979        PMID: 507283     DOI: 10.4269/ajtmh.1979.28.1060

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

1.  Candidate vectors and rodent hosts of Venezuelan equine encephalitis virus, Chiapas, 2006-2007.

Authors:  Eleanor R Deardorff; Jose G Estrada-Franco; Jerome E Freier; Roberto Navarro-Lopez; Amelia Travassos Da Rosa; Robert B Tesh; Scott C Weaver
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Evolutionary patterns of eastern equine encephalitis virus in North versus South America suggest ecological differences and taxonomic revision.

Authors:  Nicole C Arrigo; A Paige Adams; Scott C Weaver
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

3.  A putative receptor for Venezuelan equine encephalitis virus from mosquito cells.

Authors:  G V Ludwig; J P Kondig; J F Smith
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Positively charged amino acid substitutions in the e2 envelope glycoprotein are associated with the emergence of venezuelan equine encephalitis virus.

Authors:  Aaron C Brault; Ann M Powers; Edward C Holmes; C H Woelk; Scott C Weaver
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  Analysis of intrahost variation in Venezuelan equine encephalitis virus reveals repeated deletions in the 6-kilodalton protein gene.

Authors:  N L Forrester; M Guerbois; A P Adams; X Liang; S C Weaver
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

6.  Venezuelan equine encephalitis emergence: enhanced vector infection from a single amino acid substitution in the envelope glycoprotein.

Authors:  Aaron C Brault; Ann M Powers; Diana Ortiz; Jose G Estrada-Franco; Roberto Navarro-Lopez; Scott C Weaver
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-26       Impact factor: 11.205

7.  Vector-borne transmission imposes a severe bottleneck on an RNA virus population.

Authors:  Naomi L Forrester; Mathilde Guerbois; Robert L Seymour; Heidi Spratt; Scott C Weaver
Journal:  PLoS Pathog       Date:  2012-09-13       Impact factor: 6.823

8.  Venezuelan equine encephalitis virus, southern Mexico.

Authors:  José G Estrada-Franco; Roberto Navarro-Lopez; Jerome E Freier; Dionicio Cordova; Tamara Clements; Abelardo Moncayo; Wenli Kang; Carlos Gomez-Hernandez; Gabriela Rodriguez-Dominguez; George V Ludwig; Scott C Weaver
Journal:  Emerg Infect Dis       Date:  2004-12       Impact factor: 6.883

9.  Natural enzootic vectors of Venezuelan equine encephalitis virus, Magdalena Valley, Colombia.

Authors:  Cristina Ferro; Jorge Boshell; Abelardo C Moncayo; Marta Gonzalez; Marta L Ahumada; Wenli Kang; Scott C Weaver
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

10.  Venezuelan equine encephalitis virus in Iquitos, Peru: urban transmission of a sylvatic strain.

Authors:  Amy C Morrison; Brett M Forshey; Desiree Notyce; Helvio Astete; Victor Lopez; Claudio Rocha; Rebecca Carrion; Cristhiam Carey; Dominique Eza; Joel M Montgomery; Tadeusz J Kochel
Journal:  PLoS Negl Trop Dis       Date:  2008-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.